Whole Body Health Sale

Abstracts

Vitamin B3: 372 Citations

1: [No authors listed]
Niacin aids cholesterol control. But choose "extended release" to minimize
"flushing" risk.
Heart Advis. 2003 Jul;6(7):3.
PMID: 12921040

2: Morgan JM, Capuzzi DM, Baksh RI, Intenzo C, Carey CM, Reese D, Walker K.
Effects of extended-release niacin on lipoprotein subclass distribution.
Am J Cardiol. 2003 Jun 15;91(12):1432-6.
PMID: 12804729

3: Capuzzi DM, Morgan JM, Weiss RJ, Chitra RR, Hutchinson HG, Cressman MD.
Beneficial effects of rosuvastatin alone and in combination with
extended-release niacin in patients with a combined hyperlipidemia and low
high-density lipoprotein cholesterol levels.
Am J Cardiol. 2003 Jun 1;91(11):1304-10.
PMID: 12767421

4: Velling DA, Dodick DW, Muir JJ.
Sustained-release niacin for prevention of migraine headache.
Mayo Clin Proc. 2003 Jun;78(6):770-1.
PMID: 12934790

5: Miller M.
Niacin as a component of combination therapy for dyslipidemia.
Mayo Clin Proc. 2003 Jun;78(6):735-42. Review.
PMID: 12934785

6: McKenney J.
Niacin for dyslipidemia: considerations in product selection.
Am J Health Syst Pharm. 2003 May 15;60(10):995-1005.
PMID: 12789870

7: Bays HE, Dujovne CA, McGovern ME, White TE, Kashyap ML, Hutcheson AG, Crouse JR; ADvicor Versus Other Cholesterol-Modulating Agents Trial Evaluation.
Comparison of once-daily, niacin extended-release/lovastatin with standard
doses of atorvastatin and simvastatin (the ADvicor Versus Other
Cholesterol-Modulating Agents Trial Evaluation [ADVOCATE]).
Am J Cardiol. 2003 Mar 15;91(6):667-72.
PMID: 12633795

8: Hunninghake DB, McGovern ME, Koren M, Brazg R, Murdock D, Weiss S, Pearson T.
A dose-ranging study of a new, once-daily, dual-component drug product
containing niacin extended-release and lovastatin.
Clin Cardiol. 2003 Mar;26(3):112-8.
PMID: 12685616

9: Kastelein J.
What future for combination therapies?
Int J Clin Pract Suppl. 2003 Mar;(134):45-50. Review.
PMID: 12793597

10: Yim BT, Chong PH.
Niacin-ER and lovastatin treatment of hypercholesterolemia and mixed dyslipidemia.
Ann Pharmacother. 2003 Jan;37(1):106-15. Review.
PMID: 12503944

11: Moon YS, Kashyap ML.
Niacin extended-release/lovastatin: combination therapy for lipid disorders.
Expert Opin Pharmacother. 2002 Dec;3(12):1763-71. Review.
PMID: 12472373

12: Duvall WL, Blazing MA, Saxena S, Guyton JR.
Targeting cardiovascular risk associated with both low density and high density
lipoproteins using statin-niacin combination therapy.
J Cardiovasc Risk. 2002 Dec;9(6):339-47.
PMID: 12478203

13: [No authors listed]
Niacin seems OK for people with diabetes.
Health News. 2002 Oct;8(10):7-8.
PMID: 12416488

14: Ito MK.
Niacin-based therapy for dyslipidemia: past evidence and future advances.
Am J Manag Care. 2002 Sep;8(12 Suppl):S315-22. Review.
PMID: 12240703

15: Pieper JA.
Understanding niacin formulations.
Am J Manag Care. 2002 Sep;8(12 Suppl):S308-14. Review.
PMID: 12240702

16: Pan J, Van JT, Chan E, Kesala RL, Lin M, Charles MA.
Extended-release niacin treatment of the atherogenic lipid profile and
lipoprotein(a) in diabetes.
Metabolism. 2002 Sep;51(9):1120-7.
PMID: 12200755

17: Grundy SM, Vega GL, McGovern ME, Tulloch BR, Kendall DM, Fitz-Patrick D,
Ganda OP, Rosenson RS, Buse JB, Robertson DD, Sheehan JP; Diabetes Multicenter
Research Group.
Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial.
Arch Intern Med. 2002 Jul 22;162(14):1568-76.
PMID: 12123399

18: Kuvin JT, Ramet ME, Patel AR, Pandian NG, Mendelsohn ME, Karas RH.
A novel mechanism for the beneficial vascular effects of high-density
lipoprotein cholesterol: enhanced vasorelaxation and increased endothelial
nitric oxide synthase expression.
Am Heart J. 2002 Jul;144(1):165-72.
PMID: 12094204

19: Pan J, Lin M, Kesala RL, Van J, Charles MA.
Niacin treatment of the atherogenic lipid profile and Lp(a) in diabetes.
Diabetes Obes Metab. 2002 Jul;4(4):255-61.
PMID: 12099974

20: Kashyap ML, McGovern ME, Berra K, Guyton JR, Kwiterovich PO, Harper WL,
Toth PD, Favrot LK, Kerzner B, Nash SD, Bays HE, Simmons PD.
Long-term safety and efficacy of a once-daily niacin/lovastatin formulation for patients with dyslipidemia.
Am J Cardiol. 2002 Mar 15;89(6):672-8.
PMID: 11897208

21: Stein EA.
Managing dyslipidemia in the high-risk patient.
Am J Cardiol. 2002 Mar 7;89(5A):50C-57C. Review.
PMID: 11900720

22: Wink J, Giacoppe G, King J.
Effect of very-low-dose niacin on high-density lipoprotein in patients undergoing long-term statin therapy.
Am Heart J. 2002 Mar;143(3):514-8.
PMID: 11868059

23: Gupta EK, Ito MK.
Lovastatin and extended-release niacin combination product: the first drug combination for the management of hyperlipidemia.
Heart Dis. 2002 Mar-Apr;4(2):124-37. Review.
PMID: 11975844

24: Taher TH, Dzavik V, Reteff EM, Pearson GJ, Woloschuk BL, Francis GA.
Tolerability of statin-fibrate and statin-niacin combination therapy in dyslipidemic patients at high risk for cardiovascular events.
Am J Cardiol. 2002 Feb 15;89(4):390-4.
PMID: 11835917

25: SoRelle R.
Niacin-simvastatin combination benefits patients with coronary artery disease.
Circulation. 2001 Dec 11;104(24):E9050-60.
PMID: 11764785

26: Kane MP, Hamilton RA, Addesse E, Busch RS, Bakst G.
Cholesterol and glycemic effects of Niaspan in patients with type 2 diabetes.
Pharmacotherapy. 2001 Dec;21(12):1473-8.
PMID: 11765300

27: Brown BG, Zhao XQ, Chait A, Fisher LD, Cheung MC, Morse JS, Dowdy AA,
Marino EK, Bolson EL, Alaupovic P, Frohlich J, Albers JJ.
Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease.
N Engl J Med. 2001 Nov 29;345(22):1583-92. Summary for patients in: Curr Cardiol
Rep. 2002 Nov;4(6):486.
PMID: 11757504

28: Jacobson TA.
Combination lipid-altering therapy: an emerging treatment paradigm for the 21st century.
Curr Atheroscler Rep. 2001 Sep;3(5):373-82. Review.
PMID: 11487448

29: McKenney JM, McCormick LS, Schaefer EJ, Black DM, Watkins ML.
Effect of niacin and atorvastatin on lipoprotein subclasses in patients with
atherogenic dyslipidemia.
Am J Cardiol. 2001 Aug 1;88(3):270-4.
PMID: 11472706

30: Wolfe ML, Vartanian SF, Ross JL, Bansavich LL, Mohler ER 3rd, Meagher E,
Friedrich CA, Rader DJ.
Safety and effectiveness of Niaspan when added sequentially to a statin for
treatment of dyslipidemia.
Am J Cardiol. 2001 Feb 15;87(4):476-9, A7.
PMID: 11179541

31: Tavintharan S, Kashyap ML.
The benefits of niacin in atherosclerosis.
Curr Atheroscler Rep. 2001 Jan;3(1):74-82. Review.
PMID: 11123852

32: Gedye A.
Hypothesized treatment for migraines using low doses of tryptophan, niacin,
calcium, caffeine, and acetylsalicylic acid.
Med Hypotheses. 2001 Jan;56(1):91-4.
PMID: 11133261

33: Robinson AW, Sloan HL, Arnold G.
Use of niacin in the prevention and management of hyperlipidemia.
Prog Cardiovasc Nurs. 2001 Winter;16(1):14-20. Review.
PMID: 11252872

34: Sprecher DL.
Raising high-density lipoprotein cholesterol with niacin and fibrates: a
comparative review.
Am J Cardiol. 2000 Dec 21;86(12A):46L-50L. Review.
PMID: 11374856

35: Knopp RH.
Evaluating niacin in its various forms.
Am J Cardiol. 2000 Dec 21;86(12A):51L-56L.
PMID: 11374857

36: Pearson TA.
Divergent approaches to the treatment of dyslipidemia with low levels of
high-density lipoprotein cholesterol.
Am J Cardiol. 2000 Dec 21;86(12A):57L-61L. Review.
PMID: 11374858

37: Arntz HR, Agrawal R, Wunderlich W, Schnitzer L, Stern R, Fischer F,
Schultheiss HP.
Beneficial effects of pravastatin (+/-colestyramine/niacin) initiated
immediately after a coronary event (the randomized Lipid-Coronary Artery Disease
[L-CAD] Study).
Am J Cardiol. 2000 Dec 15;86(12):1293-8.
PMID: 11113401

38: Garg R, Elam MB, Crouse JR 3rd, Davis KB, Kennedy JW, Egan D, Herd JA,
Hunninghake DB, Johnson WC, Kostis JB, Sheps DS, Applegate WB.
Effective and safe modification of multiple atherosclerotic risk factors in
patients with peripheral arterial disease.
Am Heart J. 2000 Nov;140(5):792-803.
PMID: 11054628

39: Chesney CM, Elam MB, Herd JA, Davis KB, Garg R, Hunninghake D, Kennedy JW,
Applegate WB.
Effect of niacin, warfarin, and antioxidant therapy on coagulation parameters
in patients with peripheral arterial disease in the Arterial Disease Multiple
Intervention Trial (ADMIT).
Am Heart J. 2000 Oct;140(4):631-6.
PMID: 11011338

40: Elam MB, Hunninghake DB, Davis KB, Garg R, Johnson C, Egan D, Kostis JB,
Sheps DS, Brinton EA.
Effect of niacin on lipid and lipoprotein levels and glycemic control in
patients with diabetes and peripheral arterial disease: the ADMIT study: A
randomized trial. Arterial Disease Multiple Intervention Trial.
JAMA. 2000 Sep 13;284(10):1263-70.
PMID: 10979113

41: Mack WJ, Xiang M, Shircore AM, Selzer RH, Hodis HN, Azen SP.
Efficacy of two lipid-lowering treatments on quantitative coronary angiographic endpoints.
Cardiovasc Drugs Ther. 2000 Aug;14(4):411-8.
PMID: 10999648

42: Lomnicky Y, Haimov T, Luria MH, Friedman M, Hoffman A.
Pharmacodynamic effects of bezafibrate and niacin combination: implications of
the mode of administration.
J Pharm Sci. 2000 Aug;89(8):1046-53.
PMID: 10906728

43: Morato Hernandez ML, Ichazo Cerro MS, Alvarado Vega AG, Zamora Gonzalez J,
Cardoso Saldana GC, Posadas Romero C.
[Efficacy and safety of immediate-release niacin in patients with ischemic
cardiopathy. Experience of the Instituto Nacional de Cardiologia "Ignacio
Chavez"]
Arch Inst Cardiol Mex. 2000 Jul-Aug;70(4):367-76. Spanish.
PMID: 11075282

44: Goldberg A, Alagona P Jr, Capuzzi DM, Guyton J, Morgan JM, Rodgers J,
Sachson R, Samuel P.
Multiple-dose efficacy and safety of an extended-release form of niacin in the
management of hyperlipidemia.
Am J Cardiol. 2000 May 1;85(9):1100-5.
PMID: 10781759

45: Guyton JR, Blazing MA, Hagar J, Kashyap ML, Knopp RH, McKenney JM, Nash DT, Nash SD.
Extended-release niacin vs gemfibrozil for the treatment of low levels of
high-density lipoprotein cholesterol. Niaspan-Gemfibrozil Study Group.
Arch Intern Med. 2000 Apr 24;160(8):1177-84.
PMID: 10789612

46: Zema MJ.
Gemfibrozil, nicotinic acid and combination therapy in patients with isolated
hypoalphalipoproteinemia: a randomized, open-label, crossover study.
J Am Coll Cardiol. 2000 Mar 1;35(3):640-6.
PMID: 10716466

47: Capuzzi DM, Morgan JM, Brusco OA Jr, Intenzo CM.
Niacin dosing: relationship to benefits and adverse effects.
Curr Atheroscler Rep. 2000 Jan;2(1):64-71. Review.
PMID: 11122726

48: Crawford V, Scheckenbach R, Preuss HG.
Effects of niacin-bound chromium supplementation on body composition in overweight African-American women.
Diabetes Obes Metab. 1999 Nov;1(6):331-7.
PMID: 11225649

49: Murray MF.
Niacin as a potential AIDS preventive factor.
Med Hypotheses. 1999 Nov;53(5):375-9.
PMID: 10616035

50: Udut VV, Kairov GT, Borodulina EV, V'iugova LM.
[The duration of the action of a single dose of aspirin, kurantil and nicotinic
acid during pregnancy complicated by EPH gestosis]
Eksp Klin Farmakol. 1999 May-Jun;62(3):37-9. Russian.
PMID: 10439946

51: Sposito AC, Caramelli B, Serrano CV Jr, Mansur AP, Ramires JA.
Effect of niacin and etofibrate association on subjects with coronary artery
disease and serum high-density lipoprotein cholesterol <35 mg/dl.
Am J Cardiol. 1999 Jan 1;83(1):98-100, A8.
PMID: 10073791

52: Gensler HL, Williams T, Huang AC, Jacobson EL.
Oral niacin prevents photocarcinogenesis and photoimmunosuppression in mice.
Nutr Cancer. 1999;34(1):36-41.
PMID: 10453439

53: Capuzzi DM, Guyton JR, Morgan JM, Goldberg AC, Kreisberg RA, Brusco OA, Brody J.
Efficacy and safety of an extended-release niacin (Niaspan): a long-term study.
Am J Cardiol. 1998 Dec 17;82(12A):74U-81U; discussion 85U-86U.
PMID: 9915666

54: Guyton JR, Capuzzi DM.
Treatment of hyperlipidemia with combined niacin-statin regimens.
Am J Cardiol. 1998 Dec 17;82(12A):82U-84U; discussion 85-86U. Review.
PMID: 9915667

55: Guyton JR.
Effect of niacin on atherosclerotic cardiovascular disease.
Am J Cardiol. 1998 Dec 17;82(12A):18U-23U; discussion 39U-41U. Review.
PMID: 9915658

56: Knopp RH.
Clinical profiles of plain versus sustained-release niacin (Niaspan) and the
physiologic rationale for nighttime dosing.
Am J Cardiol. 1998 Dec 17;82(12A):24U-28U; discussion 39U-41U. Review.
PMID: 9915659

57: Morgan JM, Capuzzi DM, Guyton JR.
A new extended-release niacin (Niaspan): efficacy, tolerability, and safety in
hypercholesterolemic patients.
Am J Cardiol. 1998 Dec 17;82(12A):29U-34U; discussion 39U-41U.
PMID: 9915660

58: Goldberg AC.
Clinical trial experience with extended-release niacin (Niaspan):
dose-escalation study.
Am J Cardiol. 1998 Dec 17;82(12A):35U-38U; discussion 39U-41U.
PMID: 9915661

59: Lomnicky Y, Friedman M, Luria MH, Raz I, Hoffman A.
The effect of the mode of administration on the hypolipidaemic activity of
niacin: continuous gastrointestinal administration of low-dose niacin improves
lipid-lowering efficacy in experimentally-induced hyperlipidaemic rats.
J Pharm Pharmacol. 1998 Nov;50(11):1233-9.
PMID: 9877308

60: Guyton JR, Goldberg AC, Kreisberg RA, Sprecher DL, Superko HR, O'Connor CM.

Effectiveness of once-nightly dosing of extended-release niacin alone and in
combination for hypercholesterolemia.
Am J Cardiol. 1998 Sep 15;82(6):737-43.
PMID: 9761083

61: Philipp CS, Cisar LA, Saidi P, Kostis JB.
Effect of niacin supplementation on fibrinogen levels in patients with
peripheral vascular disease.
Am J Cardiol. 1998 Sep 1;82(5):697-9, A9.
PMID: 9732910

62: Knopp RH, Alagona P, Davidson M, Goldberg AC, Kafonek SD, Kashyap M,
Sprecher D, Superko HR, Jenkins S, Marcovina S.
Equivalent efficacy of a time-release form of niacin (Niaspan) given
once-a-night versus plain niacin in the management of hyperlipidemia.
Metabolism. 1998 Sep;47(9):1097-104.
PMID: 9751239

63: Chojnowska-Jezierska J, Adamska-Dyniewska H.
Efficacy and safety of one-year treatment with slow-release nicotinic acid.
Monitoring of drug concentration in serum.
Int J Clin Pharmacol Ther. 1998 Jun;36(6):326-32.
PMID: 9660040

64: Khullar P, Khar RK, Agarwal SP.
Evaluation of hydrogel-based controlled-release niacin tablets.
Drug Dev Ind Pharm. 1998 May;24(5):479-83.
PMID: 9876611

65: Mylonaki-Charalambours E, Mourelatos D, Kotsis A.
A comparative study of the cytogenetic and antineoplasmatic effects induced by
carboplatin in combination with niacin in human lymphocytes in vitro and in
Ehrlich ascites tumor cells in vivo.
Chemotherapy. 1998 Mar-Apr;44(2):121-8.
PMID: 9551243

66: Brown BG, Zambon A, Poulin D, Rocha A, Maher VM, Davis JW, Albers JJ,
Brunzell JD.
Use of niacin, statins, and resins in patients with combined hyperlipidemia.
Am J Cardiol. 1998 Feb 26;81(4A):52B-59B. Review.
PMID: 9526815

67: Drackley JK, LaCount DW, Elliott JP, Klusmeyer TH, Overton TR, Clark JH,
Blum SA.
Supplemental fat and nicotinic acid for Holstein cows during an entire
lactation.
J Dairy Sci. 1998 Jan;81(1):201-14.
PMID: 9493095

68: [No authors listed]
ASHP Therapeutic Position Statement on the safe use of niacin in the management
of dyslipidemias. American Society of Health-System Pharmacists.
Am J Health Syst Pharm. 1997 Dec 15;54(24):2815-9.
PMID: 9428952

69: Basinskii SN, Krasnogorskaia VN.
[New method of atherosclerotic macular dystrophies treatment]
Vestn Oftalmol. 1997 Nov-Dec;113(6):17-9. Russian.
PMID: 9483992

70: Kegley EB, Spears JW, Eisemann JH.
Performance and glucose metabolism in calves fed a chromium-nicotinic acid
complex or chromium chloride.
J Dairy Sci. 1997 Aug;80(8):1744-50.
PMID: 9276815

71: Brown BG, Bardsley J, Poulin D, Hillger LA, Dowdy A, Maher VM, Zhao XQ,
Albers JJ, Knopp RH.
Moderate dose, three-drug therapy with niacin, lovastatin, and colestipol to
reduce low-density lipoprotein cholesterol <100 mg/dl in patients with
hyperlipidemia and coronary artery disease.
Am J Cardiol. 1997 Jul 15;80(2):111-5.
PMID: 9230143

72: Gardner SF, Marx MA, White LM, Granberry MC, Skelton DR, Fonseca VA.
Combination of low-dose niacin and pravastatin improves the lipid profile in
diabetic patients without compromising glycemic control.
Ann Pharmacother. 1997 Jun;31(6):677-82.
PMID: 9184704

73: Johansson JO, Egberg N, Asplund-Carlson A, Carlson LA.
Nicotinic acid treatment shifts the fibrinolytic balance favourably and
decreases plasma fibrinogen in hypertriglyceridaemic men.
J Cardiovasc Risk. 1997 Jun;4(3):165-71.
PMID: 9475670

74: O'Keefe JH, Harris WS.
Nicotinic acid--the underused ally in the fight against coronary disease.
J Cardiovasc Risk. 1997 Jun;4(3):161-3. Review.
PMID: 9475669

75: Mostaza JM, Schulz I, Vega GL, Grundy SM.
Comparison of pravastatin with crystalline nicotinic acid monotherapy in
treatment of combined hyperlipidemia.
Am J Cardiol. 1997 May 1;79(9):1298-301.
PMID: 9164913

76: O'Connor PJ, Rush WA, Trence DL.
Relative effectiveness of niacin and lovastatin for treatment of dyslipidemias
in a health maintenance organization.
J Fam Pract. 1997 May;44(5):462-7.
PMID: 9152263

77: Aronov DM, Keenan JM, Akhmedzhanov NM, Perova NV, Oganov RY, Kiseleva NY.
Clinical trial of wax-matrix sustained-release niacin in a Russian population
with hypercholesterolemia.
Arch Fam Med. 1996 Nov-Dec;5(10):567-75.
PMID: 8930228

78: Spencer GA, Wirebaugh S, Whitney EJ.
Effect of a combination of gemfibrozil and niacin on lipid levels.
J Clin Pharmacol. 1996 Aug;36(8):696-700.
PMID: 8877672

79: Gardner SF, Schneider EF, Granberry MC, Carter IR.
Combination therapy with low-dose lovastatin and niacin is as effective as
higher-dose lovastatin.
Pharmacotherapy. 1996 May-Jun;16(3):419-23.
PMID: 8726600

80: Crouse JR 3rd.
New developments in the use of niacin for treatment of hyperlipidemia: new
considerations in the use of an old drug.
Coron Artery Dis. 1996 Apr;7(4):321-6. Review.
PMID: 8853585

81: Zhang B, Zhang Q, Lu S.
[Prevention and treatment effect of niacin on FES: experimental study]
Zhonghua Yi Xue Za Zhi. 1996 Jan;76(1):9-12. Chinese.
PMID: 8758455

82: O'Keefe JH Jr, Harris WS, Nelson J, Windsor SL.
Effects of pravastatin with niacin or magnesium on lipid levels and
postprandial lipemia.
Am J Cardiol. 1995 Sep 1;76(7):480-4.
PMID: 7653448

83: Brown WV.
Niacin for lipid disorders. Indications, effectiveness, and safety.
Postgrad Med. 1995 Aug;98(2):185-9, 192-3. Review.
PMID: 7630846

84: Vacek JL, Dittmeier G, Chiarelli T, White J, Bell HH.
Comparison of lovastatin (20 mg) and nicotinic acid (1.2 g) with either drug
alone for type II hyperlipoproteinemia.
Am J Cardiol. 1995 Jul 15;76(3):182-4.
PMID: 7611158

85: Lal SM, Hewett JE, Petroski GF, Van Stone JC, Ross G Jr.
Effects of nicotinic acid and lovastatin in renal transplant patients: a
prospective, randomized, open-labeled crossover trial.
Am J Kidney Dis. 1995 Apr;25(4):616-22.
PMID: 7702060

86: Jacobson EL, Dame AJ, Pyrek JS, Jacobson MK.
Evaluating the role of niacin in human carcinogenesis.
Biochimie. 1995;77(5):394-8. Review.
PMID: 8527495

87: Giri SN, Blaisdell R, Rucker RB, Wang Q, Hyde DM.
Amelioration of bleomycin-induced lung fibrosis in hamsters by dietary
supplementation with taurine and niacin: biochemical mechanisms.
Environ Health Perspect. 1994 Dec;102 Suppl 10:137-47.
PMID: 7535685

88: Venkatesan N, Chandrakasan G.
In vivo administration of taurine and niacin modulate cyclophosphamide-induced
lung injury.
Eur J Pharmacol. 1994 Nov 1;292(1):75-80.
PMID: 7867692

89: Tsalamandris C, Panagiotopoulos S, Sinha A, Cooper ME, Jerums G.
Complementary effects of pravastatin and nicotinic acid in the treatment of
combined hyperlipidaemia in diabetic and non-diabetic patients.
J Cardiovasc Risk. 1994 Oct;1(3):231-9.
PMID: 7621303

90: Gray DR, Morgan T, Chretien SD, Kashyap ML.
Efficacy and safety of controlled-release niacin in dyslipoproteinemic
veterans.
Ann Intern Med. 1994 Aug 15;121(4):252-8.
PMID: 7741833

91: Illingworth DR, Stein EA, Mitchel YB, Dujovne CA, Frost PH, Knopp RH, Tun P,
Zupkis RV, Greguski RA.
Comparative effects of lovastatin and niacin in primary hypercholesterolemia. A
prospective trial.
Arch Intern Med. 1994 Jul 25;154(14):1586-95.
PMID: 8031206

92: Jacobson TA, Chin MM, Fromell GJ, Jokubaitis LA, Amorosa LF.
Fluvastatin with and without niacin for hypercholesterolemia.
Am J Cardiol. 1994 Jul 15;74(2):149-54.
PMID: 8023779

93: Singh GR, Menon PS, Shah P, Virmani A.
Early onset juvenile diabetes mellitus controlled with nicotinic acid therapy.
Indian J Pediatr. 1994 Jul-Aug;61(4):441-2.
PMID: 8002078

94: Schneider F, Popa R, Mihalas G, Stefaniga P, Mihalas IG, Maties R, Mateescu
R.
Superiority of antagonic-stress composition versus nicergoline in
gerontopsychiatry.
Ann N Y Acad Sci. 1994 Jun 30;717:332-42.
PMID: 8030850

95: Jacobson TA, Jokubaitis LA, Amorosa LF.
Fluvastatin and niacin in hypercholesterolemia: a preliminary report on gender
differences in efficacy.
Am J Med. 1994 Jun 6;96(6A):64S-68S.
PMID: 8017469

96: Nagai A, Yasui S, Ozawa Y, Uno H, Konno K.
Niacin attenuates acute lung injury induced by lipopolysaccharide in the
hamster.
Eur Respir J. 1994 Jun;7(6):1125-30.
PMID: 7925883

97: Jacobson TA, Amorosa LF.
Combination therapy with fluvastatin and niacin in hypercholesterolemia: a
preliminary report on safety.
Am J Cardiol. 1994 May 26;73(14):25D-29D.
PMID: 8198020

98: Hultcrantz E, Stenquist M, Lyttkens L.
Sudden deafness: a retrospective evaluation of dextran therapy.
ORL J Otorhinolaryngol Relat Spec. 1994 May-Jun;56(3):137-42.
PMID: 7515486

99: Vega GL, Grundy SM.
Lipoprotein responses to treatment with lovastatin, gemfibrozil, and nicotinic
acid in normolipidemic patients with hypoalphalipoproteinemia.
Arch Intern Med. 1994 Jan 10;154(1):73-82.
PMID: 8267492

100: Kiseleva NG.
[Induracin, prolonged-action nicotinic acid, in the treatment of atherogenic
dyslipoproteinemia]
Klin Med (Mosk). 1994;72(3):20-4. Russian.
PMID: 7990345

101: Mack WJ, Selzer RH, Hodis HN, Erickson JK, Liu CR, Liu CH, Crawford DW,
Blankenhorn DH.
One-year reduction and longitudinal analysis of carotid intima-media thickness
associated with colestipol/niacin therapy.
Stroke. 1993 Dec;24(12):1779-83.
PMID: 8248954

102: Karmarkar DP, Rajput CS, Wagh SS, Kelkar PS.
Early onset juvenile diabetes mellitus controlled with nicotinic acid therapy.
Indian J Pediatr. 1993 Nov-Dec;60(6):825-7.
PMID: 8200710

103: Schwartz ML.
Severe reversible hyperglycemia as a consequence of niacin therapy.
Arch Intern Med. 1993 Sep 13;153(17):2050-2.
PMID: 8357290

104: Blankenhorn DH, Selzer RH, Crawford DW, Barth JD, Liu CR, Liu CH, Mack WJ,
Alaupovic P.
Beneficial effects of colestipol-niacin therapy on the common carotid artery.
Two- and four-year reduction of intima-media thickness measured by ultrasound.
Circulation. 1993 Jul;88(1):20-8.
PMID: 8319334

105: Franceschini G, Paoletti R.
Pharmacological control of hypertriglyceridemia.
Cardiovasc Drugs Ther. 1993 Jun;7(3):297-302. Review.
PMID: 8364001

106: Schectman G, Hiatt J, Hartz A.
Evaluation of the effectiveness of lipid-lowering therapy (bile acid
sequestrants, niacin, psyllium and lovastatin) for treating hypercholesterolemia
in veterans.
Am J Cardiol. 1993 Apr 1;71(10):759-65.
PMID: 8456750

107: Luria MH, Sapoznikov D.
Raising HDL cholesterol with low-dose nicotinic acid and bezafibrate:
preliminary experience.
Postgrad Med J. 1993 Apr;69(810):296-9.
PMID: 8321794

108: Schmidt EB, Illingworth DR, Bacon S, Russell SJ, Thatcher SR, Mahley RW,
Weisgraber KH.
Hypolipidemic effects of nicotinic acid in patients with familial defective
apolipoprotein B-100.
Metabolism. 1993 Feb;42(2):137-9.
PMID: 8474308

109: Oganov RG, Kiseleva NG, Aronov DM, Akhmedzhanov NM, Olfer'ev AM, Kiseleva
NS, Perova NV.
[The use of Enduracin--a prolonged-action form of nicotinic acid--in correcting
atherogenic dyslipidemias]
Kardiologiia. 1993;33(10):54-9, 6. Russian.
PMID: 8139175

110: Wang Q, Hyde DM, Giri SN.
Abatement of bleomycin-induced increases in vascular permeability, inflammatory
cell infiltration, and fibrotic lesions in hamster lungs by combined treatment
with taurine and niacin.
Lab Invest. 1992 Aug;67(2):234-42.
PMID: 1380105

111: Zimmerman CA, Rakes AH, Daniel TE, Hopkins BA.
Influence of dietary protein and supplemental niacin on lactational performance
of cows fed normal and low fiber diets.
J Dairy Sci. 1992 Jul;75(7):1965-78.
PMID: 1323586

112: Wang Q, Hollinger MA, Giri SN.
Attenuation of amiodarone-induced lung fibrosis and phospholipidosis in
hamsters by taurine and/or niacin treatment.
J Pharmacol Exp Ther. 1992 Jul;262(1):127-32.
PMID: 1625191

113: Lavie CJ, Mailander L, Milani RV.
Marked benefit with sustained-release niacin therapy in patients with
"isolated" very low levels of high-density lipoprotein cholesterol and coronary
artery disease.
Am J Cardiol. 1992 Apr 15;69(12):1083-5.
PMID: 1561983

114: Erickson PS, Murphy MR, Clark JH.
Supplementation of dairy cow diets with calcium salts of long-chain fatty acids
and nicotinic acid in early lactation.
J Dairy Sci. 1992 Apr;75(4):1078-89.
PMID: 1315811

115: Harms RH, Bootwalla SM.
Research note: performance of single comb White Leghorn pullets as influenced
by niacin supplementation from zero to six weeks of age and subsequent layer
performance.
Poult Sci. 1992 Apr;71(4):771-4.
PMID: 1594529

116: Keenan JM, Wenz JB, Ripsin CM, Huang Z, McCaffrey DJ.
A clinical trial of oat bran and niacin in the treatment of hyperlipidemia.
J Fam Pract. 1992 Mar;34(3):313-9.
PMID: 1541958

117: Bassler TJ.
Niacin benefits.
West J Med. 1992 Feb;156(2):209.
PMID: 1536086

118: Giri SN, Wang Q.
Taurine and niacin offer a novel therapeutic modality in prevention of
chemically-induced pulmonary fibrosis in hamsters.
Adv Exp Med Biol. 1992;315:329-40.
PMID: 1380762

119: Keenan JM, Bae CY, Fontaine PL, Wenz JB, Myers S, Huang ZQ, Ripsin C.
Treatment of hypercholesterolemia: comparison of younger versus older patients
using wax-matrix sustained-release niacin.
J Am Geriatr Soc. 1992 Jan;40(1):12-8.
PMID: 1727841

120: Yersin AG, Edens FW, Simmons DG.
Tracheal cilia response to exogenous niacin in drinking water of turkey poults
infected with Bordetella avium.
Avian Dis. 1991 Oct-Dec;35(4):674-80.
PMID: 1785998

121: Krishnamurthy A, Thapar GS.
Effect of bezafibrate & nicotinic acid on triton induced hyperlipidemias in CFY
rats.
Indian J Med Res. 1991 Oct;94:395-8.
PMID: 1794899

122: Henkin Y, Oberman A, Hurst DC, Segrest JP.
Niacin revisited: clinical observations on an important but underutilized drug.
Am J Med. 1991 Sep;91(3):239-46.
PMID: 1892143

123: Wang QJ, Giri SN, Hyde DM, Li C.
Amelioration of bleomycin-induced pulmonary fibrosis in hamsters by combined
treatment with taurine and niacin.
Biochem Pharmacol. 1991 Aug 8;42(5):1115-22.
PMID: 1714734

124: Keenan JM, Fontaine PL, Wenz JB, Myers S, Huang ZQ, Ripsin CM.
Niacin revisited. A randomized, controlled trial of wax-matrix
sustained-release niacin in hypercholesterolemia.
Arch Intern Med. 1991 Jul;151(7):1424-32.
PMID: 2064495

125: Drood JM, Zimetbaum PJ, Frishman WH.
Nicotinic acid for the treatment of hyperlipoproteinemia.
J Clin Pharmacol. 1991 Jul;31(7):641-50. Review.
PMID: 1894760

126: Blankenhorn DH, Azen SP, Crawford DW, Nessim SA, Sanmarco ME, Selzer RH,
Shircore AM, Wickham EC.
Effects of colestipol-niacin therapy on human femoral atherosclerosis.
Circulation. 1991 Feb;83(2):438-47.
PMID: 1991366

127: Capurso A.
Drugs affecting triglycerides.
Cardiology. 1991;78(3):218-25. Review.
PMID: 1868499

128: Berge KG, Canner PL.
Coronary drug project: experience with niacin. Coronary Drug Project Research
Group.
Eur J Clin Pharmacol. 1991;40 Suppl 1:S49-51.
PMID: 2044644

129: Ajayi AA, Akinleye AO, Udoh SJ, Ajayi OO, Oyelese O, Ijaware CO.
The effects of prednisolone and niacin on chloroquine-induced pruritus in
malaria.
Eur J Clin Pharmacol. 1991;41(4):383-5.
PMID: 1804657

130: Palumbo PJ.
Rediscovery of crystalline niacin.
Mayo Clin Proc. 1991 Jan;66(1):112-3.
PMID: 1988752

131: Cashin-Hemphill L, Mack WJ, Pogoda JM, Sanmarco ME, Azen SP, Blankenhorn
DH.
Beneficial effects of colestipol-niacin on coronary atherosclerosis. A 4-year
follow-up.
JAMA. 1990 Dec 19;264(23):3013-7.
PMID: 2243429

132: Chernomorets NN, Kotlubei GV, Vatutin NT, Zhivotovskaia IA, Gnilitskaia VB,
Alifanova RE, Lobach EIa, Mal'tseva NV, Mitrofanov AN.
[The effect of tocopherol and nicotinic acid on the microcirculation and blood
coagulability in patients with ischemic heart disease]
Vrach Delo. 1990 Dec;(12):6-8. Russian.
PMID: 2089804

133: Tornvall P, Hamsten A, Johansson J, Carlson LA.
Normalisation of the composition of very low density lipoprotein in
hypertriglyceridemia by nicotinic acid.
Atherosclerosis. 1990 Oct;84(2-3):219-27.
PMID: 2282100

134: Wu FF, Gray DR.
Promotion of extended-release niacin tablets at a Veterans Affairs medical
center.
Am J Hosp Pharm. 1990 Sep;47(9):2031-4.
PMID: 2220857

135: Garg A, Grundy SM.
Nicotinic acid as therapy for dyslipidemia in non-insulin-dependent diabetes
mellitus.
JAMA. 1990 Aug 8;264(6):723-6.
PMID: 2374275

136: Johansson J, Carlson LA.
The effects of nicotinic acid treatment on high density lipoprotein particle
size subclass levels in hyperlipidaemic subjects.
Atherosclerosis. 1990 Aug;83(2-3):207-16.
PMID: 2242098

137: Wahlberg G, Walldius G, Olsson AG, Kirstein P.
Effects of nicotinic acid on serum cholesterol concentrations of high density
lipoprotein subfractions HDL2 and HDL3 in hyperlipoproteinaemia.
J Intern Med. 1990 Aug;228(2):151-7.
PMID: 2394966

138: Ruiz N, Harms RH, Linda SB.
Niacin requirement of broiler chickens fed a corn-soybean meal diet from 1 to
21 days of age.
Poult Sci. 1990 Mar;69(3):433-9.
PMID: 2345725

139: Im MJ, Hoopes JE.
Improved skin flap survival with nicotinic acid and nicotinamide in rats.
J Surg Res. 1989 Nov;47(5):453-5.
PMID: 2530401

140: Alderman JD, Pasternak RC, Sacks FM, Smith HS, Monrad ES, Grossman W.
Effect of a modified, well-tolerated niacin regimen on serum total cholesterol,
high density lipoprotein cholesterol and the cholesterol to high density
lipoprotein ratio.
Am J Cardiol. 1989 Oct 1;64(12):725-9.
PMID: 2801522

141: Kats GL, Zhivotovskaia IA, Gnilitskaia VB, Alifanova RE, Mal'tseva NV.
[Nicotinic acid in the treatment of chronic circulatory failure in patients
with ischemic heart disease]
Vrach Delo. 1989 Sep;(9):16-9. Russian.
PMID: 2609611

142: Taguchi S, Wada T, Kijima S, Yoshie H, Hara K, Tonomura M, Tsujita S.
[Effects of nicotinate ethyl ester treatment on gingival blood circulation of
experimental gingivitis in monkeys]
Nippon Shishubyo Gakkai Kaishi. 1989 Mar;31(1):184-99. Japanese.
PMID: 2517791

143: Datta S, Das DK, Engelman RM, Otani H, Rousou JA, Breyer RH, Klar J.
Enhanced myocardial preservation by nicotinic acid, an antilipolytic compound:
mechanism of action.
Basic Res Cardiol. 1989 Jan-Feb;84(1):63-76.
PMID: 2923608

144: Urberg M, Benyi J, John R.
Hypocholesterolemic effects of nicotinic acid and chromium supplementation.
J Fam Pract. 1988 Dec;27(6):603-6.
PMID: 3199088

145: Luria MH.
Effect of low-dose niacin on high-density lipoprotein cholesterol and total
cholesterol/high-density lipoprotein cholesterol ratio.
Arch Intern Med. 1988 Nov;148(11):2493-5.
PMID: 3190381

146: Alekseeva IA, Katserikova NV, Grishchenko NL, Isaeva VA, Klimova OA.
[Experimental evaluation of the effectiveness of vitamin-enriched chopped meat
products]
Vopr Pitan. 1988 Jul-Aug;(4):55-9. Russian.
PMID: 3232340

147: Mamedov IaD, Garaev GSh, Korkmazov BM, Mirzabekova FI.
[The structuro-functional state of the ischemic myocardium under the action of
a terrilitin-nicotinic acid mixture in animal experiments]
Biull Eksp Biol Med. 1988 May;105(5):618-20. Russian.
PMID: 2454688

148: Rachkov AK.
[Metabolic effects of succinic and nicotinic acids in emotional pain stress]
Farmakol Toksikol. 1988 May-Jun;51(3):41-5. Russian.
PMID: 3410024

149: Flachowsky G, Matthey M, Ochrimenko WI.
Influence of dietary niacin on volatile fatty acids in rumen liquid of sheep
and rumen dry matter degradability of untreated and ammonia-treated wheat straw.
Arch Tierernahr. 1988 Feb;38(2):99-108.
PMID: 2837166

150: Cohen L, Morgan J.
Effectiveness of individualized long-term therapy with niacin and probucol in
reduction of serum cholesterol.
J Fam Pract. 1988 Feb;26(2):145-50.
PMID: 3339318

151: Carpenter KJ, Schelstraete M, Vilicich VC, Wall JS.
Immature corn as a source of niacin for rats.
J Nutr. 1988 Feb;118(2):165-9.
PMID: 3339473

152: Figge HL, Figge J, Souney PF, Mutnick AH, Sacks F.
Nicotinic acid: a review of its clinical use in the treatment of lipid
disorders.
Pharmacotherapy. 1988;8(5):287-94. Review.
PMID: 3075276

153: Malloy MJ, Kane JP, Kunitake ST, Tun P.
Complementarity of colestipol, niacin, and lovastatin in treatment of severe
familial hypercholesterolemia.
Ann Intern Med. 1987 Nov;107(5):616-23.
PMID: 3662275

154: Blankenhorn DH, Nessim SA, Johnson RL, Sanmarco ME, Azen SP,
Cashin-Hemphill L.
Beneficial effects of combined colestipol-niacin therapy on coronary
atherosclerosis and coronary venous bypass grafts.
JAMA. 1987 Jun 19;257(23):3233-40. Erratum in: JAMA 1988 May 13;259(18):2698.
PMID: 3295315

155: Canner PL, Berge KG, Wenger NK, Stamler J, Friedman L, Prineas RJ,
Friedewald W.
Fifteen year mortality in Coronary Drug Project patients: long-term benefit
with niacin.
J Am Coll Cardiol. 1986 Dec;8(6):1245-55.
PMID: 3782631

156: Tlepshukov IK.
[Effect of heparin on the vascular thrombocytic link of the hemostatic system
and pathogenetic correction of ensuing disorders]
Biull Eksp Biol Med. 1986 Nov;102(11):544-5. Russian.
PMID: 3779075

157: Angelin B, Eriksson M, Einarsson K.
Combined treatment with cholestyramine and nicotinic acid in heterozygous
familial hypercholesterolaemia: effects on biliary lipid composition.
Eur J Clin Invest. 1986 Oct;16(5):391-6.
PMID: 3100307

158: Vik-Mo H, Mjos OD, Neely JR, Maroko PR, Ribeiro LG.
Limitation of myocardial infarct size by metabolic interventions that reduce
accumulation of fatty acid metabolites in ischemic myocardium.
Am Heart J. 1986 Jun;111(6):1048-54.
PMID: 3716978

159: Ruegsegger GJ, Schultz LH.
Use of a combination of propylene glycol and niacin for subclinical ketosis.
J Dairy Sci. 1986 May;69(5):1411-5.
PMID: 3722549

160: Chekalina SI, Guseva LI, Bardyechev MS.
[Use of nicotinic acid and midocalm for correcting blood coagulation in
patients with radiation edema of the extremities]
Med Radiol (Mosk). 1985 Aug;30(8):28-30. Russian.
PMID: 4033386

161: Koch MO, McDougal WS.
Nicotinic acid: treatment for the hyperchloremic acidosis following urinary
diversion through intestinal segments.
J Urol. 1985 Jul;134(1):162-4.
PMID: 4009816

162: Knopp RH, Ginsberg J, Albers JJ, Hoff C, Ogilvie JT, Warnick GR, Burrows E,
Retzlaff B, Poole M.
Contrasting effects of unmodified and time-release forms of niacin on
lipoproteins in hyperlipidemic subjects: clues to mechanism of action of niacin.
Metabolism. 1985 Jul;34(7):642-50.
PMID: 3925290

163: Nikulin AA, Rachkov AK.
[Metabolic effects of nicotinic acid in different types of experimental
vascular pathology in rabbits]
Farmakol Toksikol. 1985 May-Jun;48(3):69-74. Russian.
PMID: 2411593

164: Walldius G, Wahlberg G.
Effects of nicotinic acid and its derivatives on lipid metabolism and other
metabolic factors related to atherosclerosis.
Adv Exp Med Biol. 1985;183:281-93.
PMID: 4036701

165: Orbetsova V, Iurukova Ts, Kirov T.
[Regression of experimental cholesterol-induced atherosclerosis in rabbits
after stopping the atherogenic diet and after treatment with nicotinic acid]
Eksp Med Morfol. 1985;24(1):32-8. Bulgarian.
PMID: 4029068

166: Hoeg JM, Maher MB, Bou E, Zech LA, Bailey KR, Gregg RE, Sprecher DL, Susser
JK, Pikus AM, Brewer HB Jr.
Normalization of plasma lipoprotein concentrations in patients with type II
hyperlipoproteinemia by combined use of neomycin and niacin.
Circulation. 1984 Dec;70(6):1004-11.
PMID: 6388897

167: Dufva GS, Bartley EE, Nagaraja TG, Dayton AD, Frey RA.
Effect of dietary niacin supplementation on phlorhizin and
1,3-butanediol-induced ketonemia and hypoglycemia in steers.
Am J Vet Res. 1984 Sep;45(9):1835-7.
PMID: 6497141

168: Hoogwerf BJ, Bantle JP, Kuba K, Frantz ID Jr, Hunninghake DB.
Treatment of type III hyperlipoproteinemia with four different treatment
regimens.
Atherosclerosis. 1984 May-Jun;51(2-3):251-9.
PMID: 6588975

169: Kresiun VI.
[Stress-protective properties of lithium nicotinate--a new derivative of
nicotinic acid]
Biull Eksp Biol Med. 1984 Mar;97(3):312-5. Russian.
PMID: 6538449

170: Odetti P, Cheli V, Carta G, Maiello M, Viviani GL.
Effect of nicotinic acid associated with retinol and tocopherols on plasma
lipids in hyperlipoproteinaemic patients.
Pharmatherapeutica. 1984;4(1):21-4.
PMID: 6390462

171: Goranov Kh, Gabrovski P, Zheliazkov S, Popgeorgieva M.
[Therapeutic and prophylactic action of monensin and nicotinic acid in cows
with subclinical ketosis]
Vet Med Nauki. 1984;21(1):43-50. Bulgarian.
PMID: 6730318

172: Farber FM.
[Treatment of primary neuritis of the facial nerve with compresses of dimexide
and nicotinic acid]
Zh Nevropatol Psikhiatr Im S S Korsakova. 1984;84(8):1161-3. Russian.
PMID: 6495938

173: Rabbani GH, Butler T, Bardhan PK, Islam A.
Reduction of fluid-loss in cholera by nicotinic acid: a randomised controlled
trial.
Lancet. 1983 Dec 24-31;2(8365-66):1439-42.
PMID: 6140541

174: Nessim SA, Chin HP, Alaupovic P, Blankenhorn DH.
Combined therapy of niacin, colestipol, and fat-controlled diet in men with
coronary bypass. Effect on blood lipids and apolipoproteins.
Arteriosclerosis. 1983 Nov-Dec;3(6):568-73.
PMID: 6651612

175: Maksimovich IaB, Kresiun VI, Ariaev VL.
[Biochemical disturbances in the chronic use of alcohol and ways to correct
them]
Ukr Biokhim Zh. 1983 Nov-Dec;55(6):643-6. Russian.
PMID: 6229075

176: Walker AR, Walker BF, Metz J.
Acceptability trials of maize meal fortified with niacin, riboflavin and folic
acid.
S Afr Med J. 1983 Sep 3;64(10):343-6.
PMID: 6612529

177: Maksimovich IaB, Kresiun VI, Ariaev VL.
[Effectiveness of lithium nicotinate in the treatment of experimental
alcoholism]
Biull Eksp Biol Med. 1983 Aug;96(8):35-7. Russian.
PMID: 6683980

178: Feeding supplemental niacin for milk production in six dairy herds.
J Dairy Sci. 1983 May;66(5):1046-51.
PMID: 6875057

179: Jaster EH, Bell DF, McPherron TA.
Nicotinic acid and serum metabolite concentrations of lactating dairy cows fed
supplemental niacin.
J Dairy Sci. 1983 May;66(5):1039-45.
PMID: 6875056

180: Shafer RB, Knodell RG, Stanley LN, Elson MK.
Acute effects of nicotinic acid on hepatic transport of 99mTc-PIPIDA.
Eur J Nucl Med. 1983;8(1):12-4.
PMID: 6832182

181: Kiuchi K, Kondo M, Ueno S, Moriguchi K, Yoshizawa K, Miyake Y, Matsumura M,
Tsubura A.
Functional rescue of N-methyl-N-nitrosourea-induced retinopathy by nicotinamide
in Sprague-Dawley rats.
Curr Eye Res. 2003 Jun;26(6):355-62.
PMID: 12868016

182: Isbir CS, Ak K, Kurtkaya O, Zeybek U, Akgun S, Scheitauer BW, Sav A,
Cobanoglu A.
Ischemic preconditioning and nicotinamide in spinal cord protection in an
experimental model of transient aortic occlusion.
Eur J Cardiothorac Surg. 2003 Jun;23(6):1028-33.
PMID: 12829083

183: Steensrud T, Nordhaug D, Elvenes OP, Korvald C, Sorlie DG.
Superior myocardial protection with nicorandil cardioplegia.
Eur J Cardiothorac Surg. 2003 May;23(5):670-7.
PMID: 12754016

184: Grote W, Claussen U, Heinz D.
[Induction and prevention of developmental abnormalities in rabbits by
administration of 6-aminonicotinic acid and nicotinic acid amide]
Arzneimittelforschung. 1971 Jun;21(6):825-8. German.
PMID: 4327352

185: Wajima Z, Yoshikawa T, Ogura A, Imanaga K, Shiga T, Inoue T, Ogawa R.
Intravenous nicorandil prevents thiamylal-fentanyl-induced bronchoconstriction
in humans.
Crit Care Med. 2003 Feb;31(2):485-90.
PMID: 12576956

186: Kurisu S, Inoue I, Kawagoe T, Ishihara M, Shimatani Y, Nishioka K, Nakamura
S, Umemura T, Yoshida M.
Usefulness of massive oral nicorandil in a patient with variant angina
refractory to conventional treatment.
Intern Med. 2003 Feb;42(2):163-7.
PMID: 12636235

187: Beal MF.
Bioenergetic approaches for neuroprotection in Parkinson's disease.
Ann Neurol. 2003;53 Suppl 3:S39-47; discussion S47-8. Review.
PMID: 12666097

188: Ungerstedt JS, Blomback M, Soderstrom T.
Nicotinamide is a potent inhibitor of proinflammatory cytokines.
Clin Exp Immunol. 2003 Jan;131(1):48-52.
PMID: 12519385

189: Falsini B, Piccardi M, Iarossi G, Fadda A, Merendino E, Valentini P.
Influence of short-term antioxidant supplementation on macular function in
age-related maculopathy: a pilot study including electrophysiologic assessment.
Ophthalmology. 2003 Jan;110(1):51-60; discussion 61.
PMID: 12511345

190: Sakamoto K, Mori K, Hashimoto T, Yancey KB, Nakashima T.
Antiepiligrin cicatricial pemphigoid of the larynx successfully treated with a
combination of tetracycline and niacinamide.
Arch Otolaryngol Head Neck Surg. 2002 Dec;128(12):1420-3.
PMID: 12479732

191: Tsubokawa A, Ueda K, Sakamoto H, Iwase T, Tamaki S.
Effect of intracoronary nicorandil administration on preventing no-reflow/slow
flow phenomenon during rotational atherectomy.
Circ J. 2002 Dec;66(12):1119-23.
PMID: 12499617

192: Hausermann P, Gutersohn T, Beltraminelli H, Schiller P, Buchner SA, Rufli
T.
[Oral pemphigus vulgaris. Successful treatment with minocycline and
nicotinamide]
Hautarzt. 2002 Dec;53(12):813-5. German.
PMID: 12444523

193: Kawai Y, Hayashi Y, Ito I, Kamibayashi T, Takada K, Kagawa K, Yamatodani A,
Mashimo T.
Nicorandil prevents epinephrine-induced arrhythmias in halothane-anesthetized
rats by nitric oxide-dependent mechanism.
Naunyn Schmiedebergs Arch Pharmacol. 2002 Dec;366(6):522-7. Epub 2002 Oct 17.
PMID: 12444492

194: Yang J, Klaidman LK, Chang ML, Kem S, Sugawara T, Chan P, Adams JD.
Nicotinamide therapy protects against both necrosis and apoptosis in a stroke
model.
Pharmacol Biochem Behav. 2002 Nov;73(4):901-10.
PMID: 12213537

195: Amato L, Coronella G, Berti S, Gallerani I, Moretti S, Fabbri P.
Successful treatment with doxycycline and nicotinamide of two cases of
persistent pemphigoid gestationis.
J Dermatolog Treat. 2002 Sep;13(3):143-6.
PMID: 12227878

196: Hakozaki T, Minwalla L, Zhuang J, Chhoa M, Matsubara A, Miyamoto K,
Greatens A, Hillebrand GG, Bissett DL, Boissy RE.
The effect of niacinamide on reducing cutaneous pigmentation and suppression of
melanosome transfer.
Br J Dermatol. 2002 Jul;147(1):20-31.
PMID: 12100180

197: Sakakibara Y, Mitha AP, Ayoub IA, Ogilvy CS, Maynard KI.
Delayed treatment with nicotinamide (vitamin B3) reduces the infarct volume
following focal cerebral ischemia in spontaneously hypertensive rats, diabetic
and non-diabetic Fischer 344 rats.
Brain Res. 2002 Mar 22;931(1):68-73.
PMID: 11897090

198: Kiuchi K, Yoshizawa K, Shikata N, Matsumura M, Tsubura A.
Nicotinamide prevents N-methyl-N-nitrosourea-induced photoreceptor cell
apoptosis in Sprague-Dawley rats and C57BL mice.
Exp Eye Res. 2002 Mar;74(3):383-92.
PMID: 12014919

199: Kaanders JH, Pop LA, Marres HA, Bruaset I, van den Hoogen FJ, Merkx MA, van
der Kogel AJ.
ARCON: experience in 215 patients with advanced head-and-neck cancer.
Int J Radiat Oncol Biol Phys. 2002 Mar 1;52(3):769-78.
PMID: 11849800

200: Ayoub IA, Maynard KI.
Therapeutic window for nicotinamide following transient focal cerebral
ischemia.
Neuroreport. 2002 Feb 11;13(2):213-6.
PMID: 11893912

201: Loo WJ, Dean D, Wojnarowska F.
A severe persistent case of recurrent pemphigoid gestationis successfully
treated with minocycline and nicotinamide.
Clin Exp Dermatol. 2001 Nov;26(8):726-7.
PMID: 11722465

202: Hassan N, Janjua MZ.
The optimum dose of nicotinamide for protection of pancreatic beta-cells
against the cytotoxic effect of streptozotocin in albino rat.
J Ayub Med Coll Abbottabad. 2001 Jul-Sep;13(3):26-30.
PMID: 11873395

203: Khanna N, Pandhi RK, Gupta S, Singh MK.
Response of chronic bullous dermatosis of childhood to a combination of dapsone
and nicotinamide.
J Eur Acad Dermatol Venereol. 2001 Jul;15(4):368.
PMID: 11730061

204: Murray MF, Langan M, MacGregor RR.
Increased plasma tryptophan in HIV-infected patients treated with pharmacologic
doses of nicotinamide.
Nutrition. 2001 Jul-Aug;17(7-8):654-6.
PMID: 11448590

205: Maynard KI, Ayoub IA, Shen CC.
Delayed multidose treatment with nicotinamide extends the degree and duration
of neuroprotection by reducing infarction and improving behavioral scores up to
two weeks following transient focal cerebral ischemia in Wistar rats.
Ann N Y Acad Sci. 2001 Jun;939:416-24.
PMID: 11462797

206: Kreyden OP, Borradori L, Trueb RM, Burg G, Nestle FO.
[Successful therapy with tetracycline and nicotinamide in cicatricial
pemphigoid]
Hautarzt. 2001 Mar;52(3):247-50. German.
PMID: 11284073

207: Izu K, Yamamoto O, Masuyuki K, Asahi M, Komai R, Yasumoto S, Hashimoto T.
[A case of pemphigus foliaceus associated with bullous impetigo successfully
treated with tetracycline and nicotinamide]
J UOEH. 2001 Mar 1;23(1):59-67. Japanese.
PMID: 11279842

208: Reddy S, Karanam M, Robinson E.
Prevention of cyclophosphamide-induced accelerated diabetes in the NOD mouse by
nicotinamide or a soy protein-based infant formula.
Int J Exp Diabetes Res. 2001;1(4):299-313.
PMID: 11467420
To here
209: Knip M, Douek IF, Moore WP, Gillmor HA, McLean AE, Bingley PJ, Gale EA;
European Nicotinamide Diabetes Intervention Trial Group.
Safety of high-dose nicotinamide: a review.
Diabetologia. 2000 Nov;43(11):1337-45. Review.
PMID: 11126400

210: Goon AT, Tan SH, Khoo LS, Tan T.
Tetracycline and nicotinamide for the treatment of bullous pemphigoid: our
experience in Singapore.
Singapore Med J. 2000 Jul;41(7):327-30.
PMID: 11026799

211: Bouzas EA, Karadimas P, Mastorakos G, Koutras DA.
Antioxidant agents in the treatment of Graves' ophthalmopathy.
Am J Ophthalmol. 2000 May;129(5):618-22.
PMID: 10844053

212: Shah SA, Ormerod AD.
Dermatitis herpetiformis effectively treated with heparin, tetracycline and
nicotinamide.
Clin Exp Dermatol. 2000 May;25(3):204-5.
PMID: 10844495

213: O'Brien BA, Harmon BV, Cameron DP, Allan DJ.
Nicotinamide prevents the development of diabetes in the
cyclophosphamide-induced NOD mouse model by reducing beta-cell apoptosis.
J Pathol. 2000 May;191(1):86-92.
PMID: 10767724

214: Malcon C, Kaddurah-Daouk R, Beal MF.
Neuroprotective effects of creatine administration against NMDA and malonate
toxicity.
Brain Res. 2000 Mar 31;860(1-2):195-8.
PMID: 10727643

215: Sakakibara Y, Mitha AP, Ogilvy CS, Maynard KI.
Post-treatment with nicotinamide (vitamin B(3)) reduces the infarct volume
following permanent focal cerebral ischemia in female Sprague-Dawley and Wistar
rats.
Neurosci Lett. 2000 Mar 10;281(2-3):111-4.
PMID: 10704755

216: McCarty MF, Russell AL.
Niacinamide therapy for osteoarthritis--does it inhibit nitric oxide synthase
induction by interleukin 1 in chondrocytes?
Med Hypotheses. 1999 Oct;53(4):350-60.
PMID: 10608273

217: Yomada M, Komai A, Hashimato T.
Sublamina densa-type linear IgA bullous dermatosis successfully treated with
oral tetracycline and niacianamide.
Br J Dermatol. 1999 Sep;141(3):608-9.
PMID: 10583104

218: Cuzzocrea S, Zingarelli B, Costantino G, Sottile A, Teti D, Caputi AP.
Protective effect of poly(ADP-ribose) synthetase inhibition on multiple organ
failure after zymosan-induced peritonitis in the rat.
Crit Care Med. 1999 Aug;27(8):1517-23.
PMID: 10470759

219: Kroger H, Hauschild A, Ohde M, Bache K, Voigt WP, Thefeldt W, Kruger D.
Nicotinamide and methionine reduce the liver toxic effect of methotrexate.
Gen Pharmacol. 1999 Aug;33(2):203-6.
PMID: 10461859

220: Visalli N, Cavallo MG, Signore A, Baroni MG, Buzzetti R, Fioriti E,
Mesturino C, Fiori R, Lucentini L, Matteoli MC, Crino A, Corbi S, Spera S,
Teodonio C, Paci F, Amoretti R, Pisano L, Suraci C, Multari G, Sulli N, Cervoni
M, De Mattia G, Faldetta MR, Boscherini B, Pozzilli P, et al.
A multi-centre randomized trial of two different doses of nicotinamide in
patients with recent-onset type 1 diabetes (the IMDIAB VI).
Diabetes Metab Res Rev. 1999 May-Jun;15(3):181-5.
PMID: 10441040

221: Dragan L, Eng AM, Lam S, Persson T.
Tetracycline and niacinamide: treatment alternatives in ocular cicatricial
pemphigoid.
Cutis. 1999 Mar;63(3):181-3.
PMID: 10190074

222: Kolb H, Burkart V.
Nicotinamide in type 1 diabetes. Mechanism of action revisited.
Diabetes Care. 1999 Mar;22 Suppl 2:B16-20. Review.
PMID: 10097894

223: Ayoub IA, Lee EJ, Ogilvy CS, Beal MF, Maynard KI.
Nicotinamide reduces infarction up to two hours after the onset of permanent
focal cerebral ischemia in Wistar rats.
Neurosci Lett. 1999 Jan 4;259(1):21-4.
PMID: 10027546

224: Beales PE, Burr LA, Webb GP, Mansfield KJ, Pozzilli P.
Diet can influence the ability of nicotinamide to prevent diabetes in the
non-obese diabetic mouse: a preliminary study.
Diabetes Metab Res Rev. 1999 Jan-Feb;15(1):21-8.
PMID: 10398543

225: el-Said A, Menke D, Dorie MJ, Brown JM.
Comparison of the effectiveness of tirapazamine and carbogen with nicotinamide
in enhancing the response of a human tumor xenograft to fractionated
irradiation.
Radiat Oncol Investig. 1999;7(3):163-9.
PMID: 10406058

226: Loginov AS, Matiushin BN, Astaf'eva OV, Nilova TV, Vinokurova LV.
[Nicotinamide in combined treatment of chronic pancreatitis]
Ter Arkh. 1999;71(8):43-6. Russian.
PMID: 10515036

227: Reiche L, Wojnarowska F, Mallon E.
Combination therapy with nicotinamide and tetracyclines for cicatricial
pemphigoid: further support for its efficacy.
Clin Exp Dermatol. 1998 Nov;23(6):254-7.
PMID: 10233619

228: Pasmans SG, Preesman AH, van Vloten WA.
[Pellagra (deficiency of vitamin B3 or of the amino acid tryptophan): a disease
still extant in the Netherlands]
Ned Tijdschr Geneeskd. 1998 Aug 15;142(33):1880-2. Dutch.
PMID: 9856171

229: Honl BA, Elston DM.
Autoimmune bullous eruption localized to a breast reconstruction site: response
to niacinamide.
Cutis. 1998 Aug;62(2):85-6.
PMID: 9714904

230: Kaanders JH, Pop LA, Marres HA, Liefers J, van den Hoogen FJ, van Daal WA,
van der Kogel AJ.
Accelerated radiotherapy with carbogen and nicotinamide (ARCON) for laryngeal
cancer.
Radiother Oncol. 1998 Aug;48(2):115-22.
PMID: 9783882

231: Lampeter EF, Klinghammer A, Scherbaum WA, Heinze E, Haastert B, Giani G,
Kolb H.
The Deutsche Nicotinamide Intervention Study: an attempt to prevent type 1
diabetes. DENIS Group.
Diabetes. 1998 Jun;47(6):980-4.
PMID: 9604880

232: Polo V, Saibene A, Pontiroli AE.
Nicotinamide improves insulin secretion and metabolic control in lean type 2
diabetic patients with secondary failure to sulphonylureas.
Acta Diabetol. 1998 Apr;35(1):61-4.
PMID: 9625292

233: Rothstein E, Scott DW, Riis RC.
Tetracycline and niacinamide for the treatment of sterile
pyogranuloma/granuloma syndrome in a dog.
J Am Anim Hosp Assoc. 1997 Nov-Dec;33(6):540-3.
PMID: 9358425

234: McLaren DB, Pickles T, Thomson T, Olive PL.
Impact of nicotinamide on human tumour hypoxic fraction measured using the
comet assay.
Radiother Oncol. 1997 Nov;45(2):175-82.
PMID: 9424009

235: Horsman MR, Siemann DW, Chaplin DJ, Overgaard J.
Nicotinamide as a radiosensitizer in tumours and normal tissues: the importance
of drug dose and timing.
Radiother Oncol. 1997 Nov;45(2):167-74.
PMID: 9424008

236: Saunders MI, Hoskin PJ, Pigott K, Powell ME, Goodchild K, Dische S,
Denekamp J, Stratford MR, Dennis MF, Rojas AM.
Accelerated radiotherapy, carbogen and nicotinamide (ARCON) in locally advanced
head and neck cancer: a feasibility study.
Radiother Oncol. 1997 Nov;45(2):159-66.
PMID: 9424007

237: Pozzilli P, Visalli N, Cavallo MG, Signore A, Baroni MG, Buzzetti R,
Fioriti E, Mesturino C, Fiori R, Romiti A, Giovannini C, Lucentini L, Matteoli
MC, Crino A, Teodonio C, Paci F, Amoretti R, Pisano L, Suraci C, Multari G,
Suppa M, Sulli N, De Mattia G, Faldetta MR, Suraci MT.
Vitamin E and nicotinamide have similar effects in maintaining residual beta
cell function in recent onset insulin-dependent diabetes (the IMDIAB IV study)
Eur J Endocrinol. 1997 Sep;137(3):234-9. Erratum in: Eur J Endocrinol 1997
Nov;137(5):558.
PMID: 9330586

238: Kim JY, Chi JK, Kim EJ, Park SY, Kim YW, Lee SK.
Inhibition of diabetes in non-obese diabetic mice by nicotinamide treatment for
5 weeks at the early age.
J Korean Med Sci. 1997 Aug;12(4):293-7.
PMID: 9288627

239: Masunaga S, Ono K, Akaboshi M, Kawai K, Suzuki M, Kinashi Y, Takagaki M.
Augmentation in chemosensitivity of intratumor quiescent cells by combined
treatment with nicotinamide and mild hyperthermia.
Jpn J Cancer Res. 1997 Aug;88(8):770-7.
PMID: 9330609

240: Masunaga S, Ono K, Suzuki M, Takagaki M, Sakurai Y, Kobayashi T, Akuta K,
Akaboshi M, Kinashi Y, Abe M.
Modification of the response of a quiescent cell population within a murine
solid tumour to boron neutron capture irradiation: studies with nicotinamide and
hyperthermia.
Br J Radiol. 1997 Apr;70(832):391-8.
PMID: 9166076

241: Legon'kova LF, Bushma MI, Zverinskii IV, Abakumov GZ, Zavodnik LV.
[The effect of nicotinamide, methionine and alpha-tocopherol on the liver
conjugating and mono-oxygenase systems and on lipid peroxidation in
hepatosis-hepatitis in rats]
Eksp Klin Farmakol. 1997 Mar-Apr;60(2):68-71. Russian.
PMID: 9206576

242: Fatigante L, Ducci F, Cartei F, Colosimo S, Marini C, Prediletto R, Danesi
R, Laddaga M, Del Tacca M, Caciagli P.
Carbogen and nicotinamide combined with unconventional radiotherapy in
glioblastoma multiforme: a new modality treatment.
Int J Radiat Oncol Biol Phys. 1997 Feb 1;37(3):499-504.
PMID: 9112444

243: Denekamp J, Fowler JF.
ARCON--current status: summary of a workshop on preclinical and clinical
studies.
Acta Oncol. 1997;36(5):517-25. Review.
PMID: 9292749

244: Hoskin PJ, Saunders MI, Phillips H, Cladd H, Powell ME, Goodchild K,
Stratford MR, Rojas A.
Carbogen and nicotinamide in the treatment of bladder cancer with radical
radiotherapy.
Br J Cancer. 1997;76(2):260-3.
PMID: 9231929

245: Pozzilli P, Browne PD, Kolb H.
Meta-analysis of nicotinamide treatment in patients with recent-onset IDDM. The
Nicotinamide Trialists.
Diabetes Care. 1996 Dec;19(12):1357-63.
PMID: 8941464

246: Hu Y, Wang Y, Wang L, Zhang H, Zhang H, Zhao B, Zhang A, Li Y.
Effects of nicotinamide on prevention and treatment of streptozotocin-induced
diabetes mellitus in rats.
Chin Med J (Engl). 1996 Nov;109(11):819-22.
PMID: 9275363

247: Greenbaum CJ, Kahn SE, Palmer JP.
Nicotinamide's effects on glucose metabolism in subjects at risk for IDDM.
Diabetes. 1996 Nov;45(11):1631-4.
PMID: 8866571

248: Elliott RB, Pilcher CC, Fergusson DM, Stewart AW.
A population based strategy to prevent insulin-dependent diabetes using
nicotinamide.
J Pediatr Endocrinol Metab. 1996 Sep-Oct;9(5):501-9.
PMID: 8961125

249: Jonas WB, Rapoza CP, Blair WF.
The effect of niacinamide on osteoarthritis: a pilot study.
Inflamm Res. 1996 Jul;45(7):330-4.
PMID: 8841834

250: Gale EA.
Theory and practice of nicotinamide trials in pre-type 1 diabetes.
J Pediatr Endocrinol Metab. 1996 May-Jun;9(3):375-9. Review.
PMID: 8887146

251: Rojas A, Vojnovic B, Johns H, Joiner MC, Martindale C, Fowler JF, Denekamp
J.
Radiosensitisation in normal tissues with oxygen, carbogen or nicotinamide:
therapeutic gain comparisons for fractionated x-ray schedules.
Radiother Oncol. 1996 Apr;39(1):53-64.
PMID: 8735494

252: Velykyi MM, Burda VA, Biront NV, Oliiarnyk OD, Velykyi AM.
[The effect of nicotinamide on the enzymatic activity of the antioxidant
defense in experimental diabetes]
Ukr Biokhim Zh. 1996 Mar-Apr;68(2):109-14. Ukrainian.
PMID: 9005653

253: Stratford MR, Dennis MF, Hoskin PJ, Saunders MI, Hodgkiss RJ, Rojas A.
Nicotinamide pharmacokinetics in normal volunteers and patients undergoing
palliative radiotherapy.
Acta Oncol. 1996;35(2):213-9.
PMID: 8639318

254: Gale EA.
Molecular mechanisms of beta-cell destruction in IDDM: the role of
nicotinamide.
Horm Res. 1996;45 Suppl 1:39-43. Review.
PMID: 8805029

255: Majamaa K, Rusanen H, Remes AM, Pyhtinen J, Hassinen IE.
Increase of blood NAD+ and attenuation of lactacidemia during nicotinamide
treatment of a patient with the MELAS syndrome.
Life Sci. 1996;58(8):691-9.
PMID: 8594319

256: Kosogorova LS, Kovalenko NN, Liubenko VA, Novosad FI.
[Recovery of immunological responsiveness in patients with bronchial asthma
during nicotinamide treatment]
Probl Tuberk. 1996;(5):41-4. Russian.
PMID: 8984491

257: Kaanders JH, Pop LA, Marres HA, van der Maazen RW, van der Kogel AJ, van
Daal WA.
Radiotherapy with carbogen breathing and nicotinamide in head and neck cancer:
feasibility and toxicity.
Radiother Oncol. 1995 Dec;37(3):190-8.
PMID: 8746587

258: Ohizumi Y, Lam GK, Pickles T, Fryer C, Chaplin DJ.
Radiosensitizing effect of nicotinamide and carbogen combined in fractionated
pions or x-rays in SCCVII tumors.
Radiat Med. 1995 Nov-Dec;13(6):291-5.
PMID: 8850370

259: Gruet P, Gaillard C, Boisrame B, Duffaut D, Grimoud AM, Camy G.
Use of an oral antiseptic bioadhesive tablet in dogs.
J Vet Dent. 1995 Sep;12(3):87-91.
PMID: 9693631

260: Ueki M, Yasunami Y, Motoyama K, Funakoshi A, Ikeda S, Tanaka M.
The amelioration of hyperglycemia in streptozotocin-induced diabetic rats after
the intraportal transplantation of an insufficient number of islets by
nicotinamide treatment.
Transplantation. 1995 Aug 27;60(4):313-7.
PMID: 7652756

261: Kolbach DN, Remme JJ, Bos WH, Jonkman MF, De Jong MC, Pas HH, van der Meer
JB.
Bullous pemphigoid successfully controlled by tetracycline and nicotinamide.
Br J Dermatol. 1995 Jul;133(1):88-90.
PMID: 7669647

262: Pozzilli P, Visalli N, Signore A, Baroni MG, Buzzetti R, Cavallo MG,
Boccuni ML, Fava D, Gragnoli C, Andreani D, et al.
Double blind trial of nicotinamide in recent-onset IDDM (the IMDIAB III study).
Diabetologia. 1995 Jul;38(7):848-52.
PMID: 7556988

263: Shalita AR, Smith JG, Parish LC, Sofman MS, Chalker DK.
Topical nicotinamide compared with clindamycin gel in the treatment of
inflammatory acne vulgaris.
Int J Dermatol. 1995 Jun;34(6):434-7.
PMID: 7657446

264: Poskitt L, Wojnarowska F.
Treatment of cicatricial pemphigoid with tetracycline and nicotinamide.
Clin Exp Dermatol. 1995 May;20(3):258-9.
PMID: 7671428

265: Thomas CD, Prade M, Guichard M.
Tumour oxygenation, radiosensitivity, and necrosis before and/or after
nicotinamide, carbogen and perflubron emulsion administration.
Int J Radiat Biol. 1995 May;67(5):597-605.
PMID: 7775835

266: Behme MT.
Nicotinamide and diabetes prevention.
Nutr Rev. 1995 May;53(5):137-9. Review.
PMID: 7666987

267: Sawai T, Kitazawa K, Danno K, Sugie N, Machizuki T, Sugiura H, Uehara M.
Pemphigus vegetans with oesophageal involvement: successful treatment with
minocycline and nicotinamide.
Br J Dermatol. 1995 Apr;132(4):668-70.
PMID: 7748766

268: Pigott K, Dische S, Saunders MI.
Short communication: the addition of carbogen and nicotinamide to a palliative
fractionation schedule for locally advanced breast cancer.
Br J Radiol. 1995 Feb;68(806):215-8.
PMID: 7537598

269: Pozzilli P, Visalli N, Buzzetti R, Baroni MG, Boccuni ML, Fioriti E,
Signore A, Mesturino C, Valente L, Cavallo MG, et al.
Adjuvant therapy in recent onset type 1 diabetes at diagnosis and insulin
requirement after 2 years.
Diabete Metab. 1995 Feb;21(1):47-9.
PMID: 7781843

270: Ueki M, Yasunami Y, Arima T, Motoyama K, Ikeda S, Tanaka M.
Protection of intrahepatic islet grafts from hyperglycemic toxicity by
nicotinamide treatment.
Transplant Proc. 1995 Feb;27(1):618.
PMID: 7879121

271: Horsman MR.
Nicotinamide and other benzamide analogs as agents for overcoming hypoxic cell
radiation resistance in tumours. A review.
Acta Oncol. 1995;34(5):571-87. Review.
PMID: 7546822

272: Mallon E, Wojnarowska F.
Cicatricial pemphigoid presenting with unusual palmar involvement, successfully
treated with a combination of nicotinamide and tetracycline.
Clin Exp Dermatol. 1994 Nov;19(6):526-30.
PMID: 7889682

273: Fivenson DP, Breneman DL, Rosen GB, Hersh CS, Cardone S, Mutasim D.
Nicotinamide and tetracycline therapy of bullous pemphigoid.
Arch Dermatol. 1994 Jun;130(6):753-8.
PMID: 8002646

274: Reimers JI, Andersen HU, Pociot F.
[Nicotinamide and prevention of insulin-dependent diabetes mellitus. Rationale,
effects, toxicology and clinical experiences. ENDIT Group]
Ugeskr Laeger. 1994 Jan 24;156(4):461-5. Review. Danish.
PMID: 8140661

275: Zackrisson B, Franzen L, Henriksson R, Littbrand B, Stratford M, Dennis M,
Rojas AM, Denekamp J.
Acute effects of accelerated radiotherapy in combination with carbogen
breathing and nicotinamide (ARCON).
Acta Oncol. 1994;33(4):377-81.
PMID: 8018369

276: Horsman MR, Nordsmark M, Khalil AA, Hill SA, Chaplin DJ, Siemann DW,
Overgaard J.
Reducing acute and chronic hypoxia in tumours by combining nicotinamide with
carbogen breathing.
Acta Oncol. 1994;33(4):371-6.
PMID: 8018368

277: Rojas AM, Johns H, Fiat PR.
Should carbogen and nicotinamide be given throughout the full course of
fractionated radiotherapy regimens?
Int J Radiat Oncol Biol Phys. 1993 Dec 1;27(5):1101-5.
PMID: 8262834

278: Elliott RB, Pilcher CC, Stewart A, Fergusson D, McGregor MA.
The use of nicotinamide in the prevention of type 1 diabetes.
Ann N Y Acad Sci. 1993 Nov 30;696:333-41.
PMID: 8109840

279: Hiromatsu Y, Sato M, Tanaka K, Ishisaka N, Kamachi J, Nonaka K.
Inhibitory effects of nicotinamide on intercellular adhesion molecule-1
expression on cultured human thyroid cells.
Immunology. 1993 Oct;80(2):330-2.
PMID: 7903279

280: Chaplin DJ, Horsman MR, Siemann DW.
Further evaluation of nicotinamide and carbogen as a strategy to reoxygenate
hypoxic cells in vivo: importance of nicotinamide dose and pre-irradiation
breathing time.
Br J Cancer. 1993 Aug;68(2):269-73.
PMID: 8347481

281: Ono K, Masunaga S, Akuta K, Akaboshi M, Abe M.
Radiosensitization of SCCVII tumours and normal tissues by nicotinamide and
carbogen: analysis by micronucleus assay.
Radiother Oncol. 1993 Aug;28(2):162-7.
PMID: 8248558

282: Shishko PI, Sadykova RE, Shmagov AIu, Ragovin KE, Abugova IA, Shamkhalova
MSh.
[Role of nicotinamide in the onset and course of streptozotocin-induced
diabetes]
Probl Endokrinol (Mosk). 1993 May-Jun;39(3):38-40. Russian.
PMID: 8058679

283: Zemtsov A, Neldner KH.
Successful treatment of dermatitis herpetiformis with tetracycline and
nicotinamide in a patient unable to tolerate dapsone.
J Am Acad Dermatol. 1993 Mar;28(3):505-6.
PMID: 8445075

284: Alio JL, Ayala MJ, Mulet E, Artola A, Bellot JL, Ruiz-Moreno JM.
Treatment of experimental acute corneal inflammation with inhibitors of the
oxidative metabolism.
Ophthalmic Res. 1993;25(5):331-6.
PMID: 8259267

285: Yourick JJ, Dawson JS, Mitcheltree LW.
Sulfur mustard-induced microvesication in hairless guinea pigs: effect of
short-term niacinamide administration.
Toxicol Appl Pharmacol. 1992 Nov;117(1):104-9.
PMID: 1440603

286: White SD, Rosychuk RA, Reinke SI, Paradis M.
Use of tetracycline and niacinamide for treatment of autoimmune skin disease in
31 dogs.
J Am Vet Med Assoc. 1992 May 15;200(10):1497-500.
PMID: 1535346

287: Peoples D, Fivenson DP.
Linear IgA bullous dermatosis: successful treatment with tetracycline and
nicotinamide.
J Am Acad Dermatol. 1992 Mar;26(3 Pt 2):498-9.
PMID: 1532966

288: Manna R, Migliore A, Martin LS, Ferrara E, Ponte E, Marietti G, Scuderi F,
Cristiano G, Ghirlanda G, Gambassi G.
Nicotinamide treatment in subjects at high risk of developing IDDM improves
insulin secretion.
Br J Clin Pract. 1992 Autumn;46(3):177-9.
PMID: 1286017

289: Michalkova D, Kolar J, Jancova E, Barak L, Silesova J.
[Early intensification of treatment in diabetes using a combination of insulin
and nicotinamide--effect on C-peptide levels and the course of the disease]
Bratisl Lek Listy. 1992 Jan;93(1):11-5. Slovak.
PMID: 1388089

290: Lee I, Kim JH, Levitt SH, Song CW.
Increases in tumor response by pentoxifylline alone or in combination with
nicotinamide.
Int J Radiat Oncol Biol Phys. 1992;22(3):425-9.
PMID: 1531211

291: Kjellen E, Joiner MC, Collier JM, Johns H, Rojas A.
A therapeutic benefit from combining normobaric carbogen or oxygen with
nicotinamide in fractionated X-ray treatments.
Radiother Oncol. 1991 Oct;22(2):81-91. Review.
PMID: 1835542

292: Elliott RB, Chase HP.
Prevention or delay of type 1 (insulin-dependent) diabetes mellitus in children
using nicotinamide.
Diabetologia. 1991 May;34(5):362-5.
PMID: 1830860

293: Dzizinskii AA, Katiubin VP.
[Clinical course and necrotic area size in patients with myocardial infarct
receiving combined treatment including antioxidants and membrane-protecting
agents]
Kardiologiia. 1991 Apr;31(4):56-8. Russian.
PMID: 1829773

294: Shneider AB.
[Anti-ischemic heart protection using thiamine and nicotinamide]
Patol Fiziol Eksp Ter. 1991 Jan-Feb;(1):9-10. Russian.
PMID: 1829150

295: Horsman MR, Chaplin DJ, Overgaard J.
The use of blood flow modifiers to improve the treatment response of solid
tumors.
Radiother Oncol. 1991;20 Suppl 1:47-52. Review.
PMID: 1826963

296: Reddy S, Bibby NJ, Elliott RB.
Early nicotinamide treatment in the NOD mouse: effects on diabetes and
insulitis suppression and autoantibody levels.
Diabetes Res. 1990 Oct;15(2):95-102.
PMID: 2151892

297: Vialettes B, Picq R, du Rostu M, Charbonnel B, Rodier M, Mirouze J, Vexiau
P, Passa P, Pehuet M, Elgrably F, et al.
A preliminary multicentre study of the treatment of recently diagnosed type 1
diabetes by combination nicotinamide-cyclosporin therapy.
Diabet Med. 1990 Sep-Oct;7(8):731-5.
PMID: 2147636

298: Masiello P, Novelli M, Fierabracci V, Bergamini E.
Protection by 3-aminobenzamide and nicotinamide against streptozotocin-induced
beta-cell toxicity in vivo and in vitro.
Res Commun Chem Pathol Pharmacol. 1990 Jul;69(1):17-32.
PMID: 2145620

299: Ludwig A, Dietel M, Schafer G, Muller K, Hilz H.
Nicotinamide and nicotinamide analogues as antitumor promoters in mouse skin.
Cancer Res. 1990 Apr 15;50(8):2470-5.
PMID: 2138506

300: Maurice DV, Jones JE, Lightsey SF, Rhoades JF.
Response of male poults to high levels of dietary niacinamide.
Poult Sci. 1990 Apr;69(4):661-8.
PMID: 2141405

301: Ovchinnikova NI.
[Rheopyrine and nicotinamide in the ambulatory treatment of acute
thrombophlebitis]
Vestn Khir Im I I Grek. 1989 Dec;144(12):48-51. Russian.
PMID: 2534725

302: Im MJ, Hoopes JE.
Improved skin flap survival with nicotinic acid and nicotinamide in rats.
J Surg Res. 1989 Nov;47(5):453-5.
PMID: 2530401

303: Smith YR, Klitzman B, Ellis MN, Kull FC Jr.
The effect of nicotinamide on microvascular density and thermal injury in rats.
J Surg Res. 1989 Nov;47(5):465-9.
PMID: 2530402

304: Dzizinskii AA, Ana'nev AA, Fuks AR.
[Effect of membrane protectors on the diastolic function of the heart in
patients with acute myocardial infarction]
Kardiologiia. 1989 Sep;29(9):52-5. Russian.
PMID: 2531814

305: Horsman MR, Chaplin DJ, Brown JM.
Tumor radiosensitization by nicotinamide: a result of improved perfusion and
oxygenation.
Radiat Res. 1989 Apr;118(1):139-50.
PMID: 2523079

306: Mendola G, Casamitjana R, Gomis R.
Effect of nicotinamide therapy upon B-cell function in newly diagnosed type 1
(insulin-dependent) diabetic patients.
Diabetologia. 1989 Mar;32(3):160-2.
PMID: 2526767

307: Shandra AA, Godlevskii LS, Mazarati AM, Makul'kin RF.
[Effect of delta sleep-inducing peptide, anticonvulsant preparations and
nicotinamide on generalized seizure activity]
Biull Eksp Biol Med. 1989 Feb;107(2):211-4. Russian.
PMID: 2522323

308: Horsman MR, Overgaard J, Christensen KL, Trotter MJ, Chaplin DJ.
Mechanism for the reduction of tumour hypoxia by nicotinamide and the clinical
relevance for radiotherapy.
Biomed Biochim Acta. 1989;48(2-3):S251-4.
PMID: 2525032

309: Iakimova K, Micheva M, Bantutova I, Ovcharov R.
[Inhibition of morphine hyperthermia, induced by nicotinamide]
Eksp Med Morfol. 1989;28(1):33-7. Bulgarian.
PMID: 2526014

310: Nurmukhambetov AN, Riabtseva TA.
[Prevention of disorders of cardiac contractility with nicotinamide in
adriblastin -related damage]
Kardiologiia. 1988 Dec;28(12):91-3. Russian.
PMID: 2977417

311: Kjellen E, Pero RW, Nilsson P.
Comparison of low dose nicotinamide versus benzamide, administered per os, as
radiosensitizers in a C3H mammary carcinoma.
Radiother Oncol. 1988 Aug;12(4):327-31.
PMID: 2973086

312: Handfield-Jones S, Jones S, Peachey R.
High dose nicotinamide in the treatment of necrobiosis lipoidica.
Br J Dermatol. 1988 May;118(5):693-6.
PMID: 2969260

313: Nikonova TV, Draudin-Krylenko VA, Bukin IuV, Turusov VS.
[Protective action of nicotinamide and pyridoxine on the initiation stage of
carcinogenesis induced in mice by procarbazine]
Eksp Onkol. 1988;10(2):17-9. Russian.
PMID: 2968902

314: Vague P, Vialettes B, Lassmann-Vague V, Vallo JJ.
Nicotinamide may extend remission phase in insulin-dependent diabetes.
Lancet. 1987 Mar 14;1(8533):619-20.
PMID: 2881146

315: Obrosova IG, Efimov AS, Velikii NN, Avramenko NL, Zubkova ST.
[Hypoglycemic effect of nicotinamide in diabetes mellitus]
Farmakol Toksikol. 1987 Mar-Apr;50(2):113-5. Russian.
PMID: 2953627

316: Horsman MR, Brown DM, Lemmon MJ, Brown JM, Lee WW.
Preferential tumor radiosensitization by analogs of nicotinamide and benzamide.
Int J Radiat Oncol Biol Phys. 1986 Aug;12(8):1307-10.
PMID: 2944859

317: Neumann R, Rappold E, Pohl-Markl H.
Treatment of polymorphous light eruption with nicotinamide: a pilot study.
Br J Dermatol. 1986 Jul;115(1):77-80.
PMID: 2942169

318: Berk MA, Lorincz AL.
The treatment of bullous pemphigoid with tetracycline and niacinamide. A
preliminary report.
Arch Dermatol. 1986 Jun;122(6):670-4.
PMID: 2940979

319: Grassetti DR.
The antimetastatic and tumor growth retarding effects of sulfur containing
analogs of nicotinamide.
Cancer Lett. 1986 May;31(2):187-95.
PMID: 2938726

320: Wahlberg G, Carlson LA, Wasserman J, Ljungqvist A.
Protective effect of nicotinamide against nephropathy in diabetic rats.
Diabetes Res. 1985 Nov;2(6):307-12.
PMID: 2934204

321: Kryzhanovskii GN, Shandra AA.
[Effect of diazepam and nicotinamide on convulsive activity of various types]
Farmakol Toksikol. 1985 Jul-Aug;48(4):21-5. Russian.
PMID: 2931304

322: Blom W, van den Berg GB, Huijmans JG, Sanders-Woudstra JA.
Successful nicotinamide treatment in an autosomal dominant behavioral and
psychiatric disorder.
J Inherit Metab Dis. 1985;8 Suppl 2:107-8.
PMID: 2931553

323: Render JA, Carlton WW.
Ocular lesions of 6-aminonicotinamide toxicosis in rabbits.
Vet Pathol. 1985 Jan;22(1):72-7.
PMID: 3156443

324: Gu CG, Chen WZ, Dong YL, Ding GS.
[Anti-arrhythmic effect of changrolin combined with nicotinamide in
experimental arrhythmia]
Zhongguo Yao Li Xue Bao. 1984 Sep;5(3):173-7. Chinese.
PMID: 6239508

325: Jonsson GG, Kjellen E, Pero RW.
Nicotinamide as a radiosensitizer of a C3H mouse mammary adenocarcinoma.
Radiother Oncol. 1984 Mar;1(4):349-53.
PMID: 6239306

326: Ma A, Medenica M.
Response of generalized granuloma annulare to high-dose niacinamide.
Arch Dermatol. 1983 Oct;119(10):836-9.
PMID: 6225398

327: Meerson FZ, Pshennikova MG, Rysmendiev AZh, Vorontsova EIa.
[Prevention of stress disorders of myocardial contractile function using
membrane protectors]
Kardiologiia. 1983 Jul;23(7):86-90. Russian.
PMID: 6225901

328: Varnakova GM.
[Use of nicotinamide for correcting the disordered nicotinic acid allowance of
patients with noncoronarogenic heart diseases]
Vopr Pitan. 1983 Jul-Aug;(4):32-5. Russian.
PMID: 6226157

329: Bakai EA, Neschetnaia LB.
[Protective properties of nicotinamide and cytochrome C in aminoglycoside
ototoxicosis]
Fiziol Zh. 1983 Jan-Feb;29(1):68-73. Russian.
PMID: 6299811

330: Berger NA, Catino DM, Vietti TJ.
Synergistic antileukemic effect of 6-aminonicotinamide and
1,3-bis(2-chloroethyl)-1-nitrosourea on L1210 cells in vitro and in vivo.
Cancer Res. 1982 Nov;42(11):4382-6.
PMID: 6215118

331: Kryzhanovskii GN, Shandra AA, Godlevskii LS.
[Effect of nicotinamide on generalized convulsions in mice]
Farmakol Toksikol. 1982 Nov-Dec;45(6):13-7. Russian.
PMID: 6217985

332: Bourgeois BF, Dodson WE, Ferrendelli JA.
Interactions between primidone, carbamazepine, and nicotinamide.
Neurology. 1982 Oct;32(10):1122-26.
PMID: 6214728

333: Kryzhanovskii GN, Shandra AA, Godlevskii LS, Nikushkin EV.
[Effect of pantogam, nicotinamide, and phenazepam on seizure activity]
Biull Eksp Biol Med. 1982 Sep;94(9):61-4. Russian.
PMID: 6216928

334: Yamada K, Nonaka K, Hanafusa T, Miyazaki A, Toyoshima H, Tarui S.
Preventive and therapeutic effects of large-dose nicotinamide injections on
diabetes associated with insulitis. An observation in nonobese diabetic (NOD)
mice.
Diabetes. 1982 Sep;31(9):749-53.
PMID: 6219022

335: Braslavskii VE, Shchavelev VA, Kryzhanovskii GN, Nikushkin EV, Germanov SB.
[Effect of nicotinamide on focal and generalized epileptic activity in the
cerebral cortex]
Biull Eksp Biol Med. 1982 Aug;94(8):39-42. Russian.
PMID: 6215072

336: Vinogradov VV, Tarasov IuA, Vodoevich VP, Borets VM, Gal'tsev VA.
[Nicotinamide as an effective agent against endogenous hypocorticism during
prolonged corticosteroid therapy]
Vopr Pitan. 1981 Sep-Oct;(5):20-3. Russian.
PMID: 6274098

337: Kryzhanovskii GN, Shandra AA, Godlevskii LS, Beliaeva AI.
[Further study of the antiepileptic properties of nicotinamide]
Biull Eksp Biol Med. 1981;91(1):42-5. Russian.
PMID: 6452183

338: Sandor S, Checiu M, Fazakas-Todea I.
Regeneration of retinal pigment epithelium damaged in rat foetuses by
6-aminonicotinamide.
Morphol Embryol (Bucur). 1981 Jan-Mar;27(1):11-3.
PMID: 6454062

339: Pamukcu AM, Milli U, Bryan GT.
Protective effect of nicotinamide on bracken fern induced carcinogenicity in
rats.
Nutr Cancer. 1981;3(2):86-93.
PMID: 6213941

340: Kryzhanovskii GN, Shandra AA.
[Use of nicotinamide and pyridoxal-5-phosphate to treat experimental epilepsy]
Zh Nevropatol Psikhiatr Im S S Korsakova. 1981;81(6):801-9. Russian.
PMID: 6457475

341: Kryzhanovskii GN, Shandra AA, Makul'kin RF, Lokasiuk BA, Godlevskii LS.
[Effect of nicotinamide on epileptic activity in the cerebral cortex]
Biull Eksp Biol Med. 1980 JUL;89(7):37-41. Russian.
PMID: 6447523

342: Kohler IK, Lorincz AL.
Erythema elevatum diutinum treated with niacinamide and tetracycline.
Arch Dermatol. 1980 Jun;116(6):693-5.
PMID: 6445715

343: Chouinard G, Young SN, Annable L, Sourkes TL.
Tryptophan-nicotinamide, imipramine and their combination in depression. A
controlled study.
Acta Psychiatr Scand. 1979 Apr;59(4):395-414.
PMID: 155389

344: Tischendorf L.
[Local nicotinamide therapy in erosive lichen of the oral mucosa]
Stomatol DDR. 1978 Dec;28(12):911-4. German.
PMID: 154199

345: Zackheim HS.
Topical 6-aminonicotinamide plus oral niacinamide therapy for psoriasis.
Arch Dermatol. 1978 Nov;114(11):1632-8.
PMID: 152612

346: Binnick SA.
Pityriasis rubra pilaris responding to aminonicotinamide.
Arch Dermatol. 1978 Sep;114(9):1348-9.
PMID: 150817

347: Kalich R, Gerloff W, Neubert R, Ulber H.
[Determination of the sensitivity of mycobacteria to pyrazinamide and
nicotinamide (author's transl)]
Z Erkr Atmungsorgane. 1978;151(2):103-12. German.
PMID: 153062

348: Otrokov AN.
[New methods of vitamin B treatment of itching dermatoses in middle aged and
aged patients]
Vestn Dermatol Venerol. 1977 Dec;(12):62-5. Russian.
PMID: 146980

349: Masiello P, Bergamini E.
Nicotinamide and streptozotocin diabetes in the rat. Factors influencing the
effectiveness of the protection.
Experientia. 1977 Sep 15;33(9):1246-7.
PMID: 142654

350: Comaish JS, Felix RH, McGrath H.
Topically applied niacinamide in isoniazid-induced pellagra.
Arch Dermatol. 1976 Jan;112(1):70-2.
PMID: 129035

351: Maitre M, Chesielski L, Lehmann A, Kempf E, Mandel P.
Protective effect of adenosine and nicotinamide against audiogenic seizure.
Biochem Pharmacol. 1974 Oct 15;23(20):2807-16.
PMID: 4154753

352: Bekier E, Wyczolkowska J, Szyc H, Maslinski C.
The inhibitory effect of nicotinamide on asthma-like symptoms and eosinophilia
in guinea pigs, anaphylactic mast cell degranulation in mice, and histamine
release from rat isolated peritoneal mast cells by compound 48-80.
Int Arch Allergy Appl Immunol. 1974;47(5):737-48.
PMID: 4139130

353: Fulton RL.
Prevention of endotoxic death with nicotinamide and adenosine triphosphate.
Surg Forum. 1974;25(0):17-9.
PMID: 4280146

354: Schein PS, Rakieten N, Cooney DA, Davis R, Vernon ML.
Streptozotocin diabetes in monkeys and dogs, and its prevention by
nicotinamide.
Proc Soc Exp Biol Med. 1973 Jun;143(2):514-8.
PMID: 4267772

355: Kintzel HW.
[Prevention of toxic hyperbilirubinemia in premature and mature newborn infants
by use of an enzyme-inducing combination: phenobarbital-nikethamide]
Helv Paediatr Acta. 1973;30:Suppl:35-7. German.
PMID: 4711239

356: Carlson LA, Froberg S, Oro L.
A case of massive hypertriglyceridemia corrected by nicotinic acid or
nicotinamide therapy.
Atherosclerosis. 1972 Nov-Dec;16(3):359-68.
PMID: 4348602

357: Hinkel GK, Kintzel HW, Schwarze R, Handel A.
[Prevention of hyperbilirubinemia in premature infants using a combination of
two enzyme inductors: phenobarbitol and nikethamide]
Dtsch Gesundheitsw. 1972 Sep 28;27(39):1854-7. German.
PMID: 4634399

358: Kintzel HW, Schwarze R, Hinkel GK.
[Prevention of transitory hyperbilirubinemia of the premature and mature
newborn infants and of the hemolytic disease of the newborn by an enzyme
induction combination: phenobarbital-nikethamide]
Schweiz Med Wochenschr. 1972 Sep 23;102(38):1339-45. German.
PMID: 4630163

359: Parkhomets PK, Kuchmerovskaia TM, Donchenko GV, Chichkovskaia GV, Klimenko AP.
[Role of nicotinic acid and its derivatives in disorders of nervous system function]
Ukr Biokhim Zh. 1995 Jul-Aug;67(4):3-11. Review. Russian.
PMID: 8553469

360: Graham AJ, Martin-Ruiz CM, Teaktong T, Ray MA, Court JA.
Human brain nicotinic receptors, their distribution and participation in neuropsychiatric disorders.
Curr Drug Target CNS Neurol Disord. 2002 Aug;1(4):387-97. Review.
PMID: 12769611

361: Bencherif M, Schmitt JD.
Targeting neuronal nicotinic receptors: a path to new therapies.
Curr Drug Target CNS Neurol Disord. 2002 Aug;1(4):349-57. Review.
PMID: 12769609

362: Rusted JM, Newhouse PA, Levin ED.
Nicotinic treatment for degenerative neuropsychiatric disorders such as Alzheimer's disease and Parkinson's disease.
Behav Brain Res. 2000 Aug;113(1-2):121-9. Review.
PMID: 10942039

363: Newhouse PA, Kelton M. Related Articles, Links
Nicotinic systems in central nervous systems disease: degenerative disorders and beyond.
Pharm Acta Helv. 2000 Mar;74(2-3):91-101. Review.
PMID: 10812945

364: OSMOND H, HOFFER A. Related Articles, Links
Massive niacin treatment in schizophrenia. Review of a nine-year study.
Lancet. 1962 Feb 10;1:316-9.
PMID: 14482545

365: Resnik HL.
Suicide prevention and niacin.
JAMA. 1969 Jun 16;208(11):2164.
PMID: 5819000

366: Wittenborn JR.
A search for responders to niacin supplementation.
Arch Gen Psychiatry. 1974 Oct;31(4):547-52.
PMID: 4607587

367: Payne IR, Walsh EM, Whittenburg EJ.
Relationship of dietary tryptophan and niacin to tryptophan metabolism
in schizophrenics and nonschizophrenics.
Am J Clin Nutr. 1974 Jun;27(6):565-71.
PMID: 4830078

368: Wittenborn JR, Weber ES, Brown M.
Niacin in the long-term treatment of schizophrenia.
Arch Gen Psychiatry. 1973 Mar;28(3):308-15.
PMID: 4569673

369: Newbold HL, Mosher LR.
Niacin and the schizophrenic patient.
Am J Psychiatry. 1970 Oct;127(4):535-6.
PMID: 4248216

370: Hawkins DR, Bortin AW, Runyon RP.
Orthomolecular psychiatry: niacin and megavitamin therapy.
Psychosomatics. 1970 Sep-Oct;11(5):517-21.
PMID: 5470684

371: Ban TA.
On-going national collaborative studies in Canada: niacin
in the treatment of schizophrenias.
Psychopharmacol Bull. 1969 Jul;5(3):5-20. Review.
PMID: 4906584

372: Petrie WM, Ban TA, Ananth JV.
The use of nicotinic acid and pyridoxine in the treatment of schizophrenia.
Int Pharmacopsychiatry. 1981;16(4):245-50.
PMID: 7040274